Pivotal generic name Toremifene Citrate Tablets are recommended to be taken orally once daily, but the time of day for best results is not specified, and can generally be taken at a fixed time of day, either before or after meals. Toremifene citrate tablets are a tamoxifen derivative with non-estrogen-dependent antitumor effects and are indicated for use in postmenopausal women with estrogen receptor-positive or unknown metastatic breast cancer. Common adverse reactions following administration are facial flushing, excessive sweating, fatigue, nausea, vaginal discharge, leukorrhea, rash, pruritus, and dizziness, usually to a mild degree. Contraindications to the use of the drug include known hypersensitivity to the product, patients with preexisting endometrial hyperplasia or severe hepatic failure, those with a prolonged QT interval, those with electrolyte disturbances, those with clinically relevant sinus bradycardia, heart failure with a reduced left ventricular ejection fraction, those with previous symptoms of cardiac arrhythmia, pregnant and breastfeeding women, and athletes should be advised to use the drug with caution. The drug is recommended to be taken orally once a day, the specific dosing time is not specified, patients can choose the oral time according to their own situation, the specific use of drugs need to follow the doctor’s instructions.